Study on the Detection and Infection Distribution of Multidrug-Resistant Organisms in Different Specimens

References

• Mücke MM, Mayer A, Kessel J, et al. Quinolone and multidrug resistance predicts failure of antibiotic prophylaxis of spontaneous bacterial peritonitis. Clin Infect Dis. 2020;70(9):1916–1924. doi:10.1093/cid/ciz540
   Web of Science ®Google Scholar
• Kronenfeld N, Zilberman-Itskovich S, Lazarovitch T, et al. The impact of improper empirical usage of antipseudomonals on admission to an acute care hospital. J Glob Antimicrob Resist. 2020;22:5–8. doi:10.1016/j.jgar.2019.12.013
   Web of Science ®Google Scholar
• Chen YY, Wu PF, Chen CS, Chen IH, Huang WT, Wang FD. Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center. BMC Infect Dis. 2020;20(1):193. doi:10.1186/s12879-020-4920-4
   Web of Science ®Google Scholar
• Wang L, Huang X, Zhou J, et al. Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients: development and validation of a novel multivariate prediction model. Antimicrob Resist Infect Control. 2020;9(1):66. doi:10.1186/s13756-020-00726-5
   PubMed Web of Science ®Google Scholar
• Octaria R, Chan A, Wolford H, et al. Web-based interactive tool to identify facilities at risk of receiving patients with multidrug-resistant organisms. Emerg Infect Dis. 2020;26(9):2046–2053. doi:10.3201/eid2609.191691
   Web of Science ®Google Scholar
• Chen HY, Jean SS, Lee YL, et al. Carbapenem-resistant enterobacterales in long-term care facilities: a global and narrative review. Front Cell Infect Microbiol. 2021;11:601968. doi:10.3389/fcimb.2021.601968
   PubMed Web of Science ®Google Scholar
• Li ZJ, Wang KW, Liu B, et al. The distribution and source of MRDOs infection: a retrospective study in 8 ICUs, 2013–2019. Infect Drug Resist. 2021;14:4983–4991. doi:10.2147/IDR.S332196
   Web of Science ®Google Scholar
• Zang F, Zhang YX, Liu B. Distribution and sources of elderly intensive care unit patients with multidrug-resistant organisms infections. Chin J Nosocomiol. 2020;30(06):866–871.
   Google Scholar
• Li ZJ, Liu B, Li HF, et al. Study on distribution and source of multi-drug resistant bacteria infection in ICUs. Chin J Nosocomiol. 2019;29(08):1166–1171.
   Google Scholar
• Howard-Anderson JR, Adams C, Dube WC, et al. Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales. Infect Control Hosp Epidemiol. 2022;2:1–7.
   Web of Science ®Google Scholar
• HMo C. Diagnostic criteria for nosocomial infection (Trial). Chin Med J. 2001;2001(5):61–67.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• (CLSI) Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 30th. Twenty-seventh informational supplement 2020 M100S; 2011.
   Google Scholar
• China Antimicrobial Resistance Surveillance System. Antimicrobial resistance of bacteria from bronchoalveolar lavage fluid: a surveillance report from china antimicrobial resistance surveillance system in 2014–2019. Chin J Infect Control. 2021;20(01):61–69.
   Google Scholar
• Committee of Expert on Rational Drug Use of the National Health Commission. China antimicrobial resistance surveillance system, national bacterial drug resistance surveillance report in 2020; 2020. Available from: http://www.carss.cn/Report/Details?aId=808. Accessed October 12, 2022.
   Google Scholar
• Bassetti S, Tschudin-Sutter S, Egli A, Osthoff M. Optimizing antibiotic therapies to reduce the risk of bacterial resistance. Eur J Intern Med. 2022;22:00039–00045.
   Google Scholar
• Barnes SL, Rock C, Harris AD, Cosgrove SE, Morgan DJ, Thom KA. The impact of reducing antibiotics on the transmission of multidrug-resistant organisms. Infect Control Hospital Epidemiol. 2017;38(06):663. doi:10.1017/ice.2017.34
   Web of Science ®Google Scholar
• Baditoiu L, Axente C, Lungeanu D, et al. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis. Ann Clin Microbiol Antimicrob. 2017;16(1):71. doi:10.1186/s12941-017-0251-8
   PubMed Web of Science ®Google Scholar
• China Antimicrobial Resistance Surveillance System. Antimicrobial resistance of bacteria: a surveillance report from China Antimicrobial Resistance Surveillance System in 2014–2019. Chin J Infect Control. 2021;20(01):15–31.
   Google Scholar
• Wei LH, Cui YL, Zhang HJ, et al. Distribution and drug resistance of bacteria isolated from bronchoalveolar lavage fluid in 74 hospitals of Gansu Province. Chin J Nosocomiol. 2021;31(22):3402–3406.
   Google Scholar
• Zhang Z, Tian L, Chen ZJ. Distribution and antimicrobial resistance of pathogens causing lower respiratory tract infection in patients in a hospital, 2013–2015. Chin J Infect Control. 2017;16(6):516–520.
   Google Scholar
• Respiratory Committee of Chinese Research Hospital Society, Expert Opinion Compilation Group on etiological diagnosis of adult respiratory infectious diseases. Expert opinion on the etiological diagnosis of adult respiratory infectious diseases. Chin J Tuberc Respir Dis. 2020;43(09):757–764.
   Google Scholar
• Xu Y, Yang H, Chen LY, et al. Current situation of Chinese clinical microbiological laboratories participating in the management of healthcare-associated infection and antimicrobial use. Chin J Infect Control. 2019;18(02):120–126.
   Google Scholar